Chinese healthcare firms expand overseas to support expat communities

Chinese healthcare companies are expanding overseas to serve growing expatriate communities in the Middle East and Southeast Asia. Distinct Healthcare plans to open a clinic in Dubai this year, while Gushengtang eyes 50 centers in the region.

Chinese healthcare companies are venturing abroad to cater to expatriate communities in regions like the Middle East and Southeast Asia, where many mainland firms are establishing operations across sectors.

“A wide range of Chinese companies are expanding overseas,” setting up local operations and bringing Chinese employees with them, said Philip Wang, CEO of Distinct Healthcare Holdings, in an interview on Monday.

“Chinese expatriate workers are often not familiar with the local healthcare system,” said Wang. “If there is a Chinese-run clinic, they may come to us. We can help bridge the language gap … or we can help connect them with some local resources to assist them.”

He added that the company plans to follow the flow of Chinese customers into international markets.

The Shenzhen-based private healthcare service provider plans to open its first clinic in Dubai, the financial hub of the United Arab Emirates, this year, after making inroads earlier into Singapore and Kuala Lumpur, Malaysia.

Meanwhile, TCM group Gushengtang eyes 50 centres in Southeast Asia to serve Chinese communities there.

On Friday, Distinct Healthcare raised HK$284.53 million (US$36.4 million) from its initial public offering (IPO) in Hong Kong, according to an exchange filing. Its stock has lost about 12 per cent since the listing, closing at HK$59.90 on Tuesday.

These moves highlight the trend of Chinese firms going global to provide familiar healthcare options for expatriates.

Related Articles

Chinese officials and executives highlighted plans to ease market access and expand services sectors at a business conference ahead of an APEC trade meeting in Suzhou.

Reported by AI

Egypt’s Ministry of Health has held talks with a US pharmaceutical company to discuss investment in healthcare and drug manufacturing. The meeting aims to attract foreign capital and boost local production capacity.

Amid energy shocks from the Iran war threatening Southeast Asia’s supply chains, US and European importers are shifting some orders back to China. Chinese exporters report a recovery in buyer numbers at the Canton Fair in Guangzhou.

Reported by AI

China's mainland stock market watchdog is discouraging the establishment of 'red-chip-structured' companies in sensitive industries, dealing a blow to tech and biotech IPO candidates. Industry sources say the move reflects regulators' caution, ensuring asset sales do not escape scrutiny.

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline